Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)
Clinical trial NCT03351608 · COMPLETED
Trial details
- NCT number
- NCT03351608
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2020-01-28
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.